Trials / Completed
CompletedNCT02292745
Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Foundation for Liver Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether combining FOLFIRINOX chemotherapy and stereotactic radiotherapy in patients with locally advanced pancreatic cancer leads to an increase in survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | stereotactic radiotherapy |
Timeline
- Start date
- 2014-12-02
- Primary completion
- 2018-05-24
- Completion
- 2018-05-24
- First posted
- 2014-11-17
- Last updated
- 2020-07-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02292745. Inclusion in this directory is not an endorsement.